PTGX
Protagonist Therapeutics Inc
137.30$
-1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -1,390.0% | – | – | – | – | – | – | -68.7% | |
| – | -4.3% | +28.3% | +28.1% | +29.8% | +373.4% | +2.8% | +8.2% | +21.4% | -1.7% | -12.6% | -55.8% | |
| – | +135.7% | +2,051.5% | +99.1% | +63.1% | +20.7% | -5.4% | +107.6% | +47.6% | +21.0% | +28.2% | +22.4% | |
| – | -90.4% | +3,923.0% | -30.5% | +42.2% | +20.8% | +1.5% | +113.4% | +33.7% | – | – | – | |
| – | -95.9% | -315.4% | – | -150.7% | – | -172.7% | – | – | – | – | – | |
| – | +33.4% | -5.0% | +75.7% | -27.0% | +99.0% | -51.3% | +133.8% | -27.8% | -23.4% | +122.5% | +17.3% | |
| – | +2,663.9% | +617.9% | – | -86.0% | -2,527.0% | +69.4% | -82.6% | – | -142.9% | +662.9% | -83.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +580,533.3% | +510.3% | -38.3% | -96.3% | +1,385.3% | +495.8% | -100.1% | -0.5% | +309.0% | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +222.8% | -100.0% | – | – | – | – | |
| – | +93.5% | +510.3% | -38.3% | -63.2% | +90.9% | +437.9% | -47.5% | -85.5% | +805.0% | -84.8% | -11.6% | |
| – | -709.8% | – | +401.5% | -127.9% | – | – | -92.8% | -65.8% | +2,833.3% | -246.7% | – | |
| – | – | – | – | -1,673.1% | – | – | – | – | – | – | -69.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.